Susan E. Morgan

1.2k total citations
10 papers, 1.0k citations indexed

About

Susan E. Morgan is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Susan E. Morgan has authored 10 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Susan E. Morgan's work include DNA Repair Mechanisms (6 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer-related Molecular Pathways (4 papers). Susan E. Morgan is often cited by papers focused on DNA Repair Mechanisms (6 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer-related Molecular Pathways (4 papers). Susan E. Morgan collaborates with scholars based in United States, Israel and Canada. Susan E. Morgan's co-authors include Michael B. Kastan, Laura Whitaker, Carrolee Barlow, Anthony Wynshaw‐Boris, Lauren D. Wood, Yang Xu, Rathinasamy Baskaran, Christine E. Canman, David Baltimore and Christine M. Lovly and has published in prestigious journals such as Nature, Molecular and Cellular Biology and Oncogene.

In The Last Decade

Susan E. Morgan

10 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan E. Morgan United States 9 860 503 243 128 102 10 1.0k
Mei-Ling Kuo United States 14 998 1.2× 596 1.2× 155 0.6× 100 0.8× 71 0.7× 17 1.2k
Natalie von der Lehr Sweden 7 984 1.1× 557 1.1× 134 0.6× 106 0.8× 141 1.4× 8 1.2k
Jennifer Brennan United States 8 867 1.0× 450 0.9× 185 0.8× 40 0.3× 79 0.8× 8 1.1k
Chun-Ju Chang United States 9 980 1.1× 529 1.1× 445 1.8× 77 0.6× 79 0.8× 10 1.3k
Yosef Shiloh Israel 7 570 0.7× 299 0.6× 178 0.7× 100 0.8× 62 0.6× 9 666
Susan C. Evans United States 19 739 0.9× 265 0.5× 117 0.5× 61 0.5× 128 1.3× 28 1.1k
Haiyun Cheng United States 9 568 0.7× 472 0.9× 193 0.8× 73 0.6× 98 1.0× 12 944
Kym L. Stanley Australia 9 588 0.7× 310 0.6× 123 0.5× 103 0.8× 146 1.4× 10 893
Zhi-Min Yuan United States 16 938 1.1× 606 1.2× 220 0.9× 104 0.8× 395 3.9× 20 1.3k
Karen Hobson Australia 14 1.5k 1.8× 925 1.8× 438 1.8× 114 0.9× 230 2.3× 17 1.7k

Countries citing papers authored by Susan E. Morgan

Since Specialization
Citations

This map shows the geographic impact of Susan E. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Morgan more than expected).

Fields of papers citing papers by Susan E. Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Morgan. The network helps show where Susan E. Morgan may publish in the future.

Co-authorship network of co-authors of Susan E. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Morgan. A scholar is included among the top collaborators of Susan E. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Morgan. Susan E. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Morgan, Susan E. & William T. Beck. (2001). Role of an Inverted CCAAT Element in Human Topoisomerase IIα Gene Expression in ICRF-187-Sensitive and -Resistant CEM Leukemic Cells. Molecular Pharmacology. 59(2). 203–211. 14 indexed citations
2.
Morgan, Susan E. & William T. Beck. (2001). Role of an Inverted CCAAT Element in Human Topoisomerase IIα Gene Expression in ICRF-187-Sensitive and -Resistant CEM Leukemic Cells. Molecular Pharmacology. 59(2). 203–211. 2 indexed citations
3.
Morgan, Susan E., Ryungsa Kim, Uppoor G. Bhat, et al.. (2000). Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells. Oncogene. 19(43). 5010–5019. 25 indexed citations
4.
Morgan, Susan E., Rhonda Cadena, Susana C. Raimondi, & William T. Beck. (2000). Selection of Human Leukemic CEM Cells for Resistance to the DNA Topoisomerase II Catalytic Inhibitor ICRF-187 Results in Increased Levels of Topoisomerase IIα and Altered G2/M Checkpoint and Apoptotic Responses. Molecular Pharmacology. 57(2). 296–307. 15 indexed citations
5.
Beck, William T., Susan E. Morgan, Yin-Yuan Mo, & Uppoor G. Bhat. (1999). Tumor cell resistance to DNA topoisomerase II inhibitors: new developments. Drug Resistance Updates. 2(6). 382–389. 31 indexed citations
6.
Morgan, Susan E., Christine M. Lovly, Tej K. Pandita, Yosef Shiloh, & Michael B. Kastan. (1997). Fragments of ATM Which Have Dominant-Negative or Complementing Activity. Molecular and Cellular Biology. 17(4). 2020–2029. 145 indexed citations
7.
Smilenov, Lubomir B., Susan E. Morgan, Satin G. Sawant, Michael B. Kastan, & Tej K. Pandita. (1997). Influence of ATM function on telomere metabolism. Oncogene. 15(22). 2659–2665. 71 indexed citations
8.
Baskaran, Rathinasamy, Lauren D. Wood, Laura Whitaker, et al.. (1997). Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature. 387(6632). 516–519. 448 indexed citations
9.
Morgan, Susan E. & Michael B. Kastan. (1997). Foundations in Cancer Research p53 and ATM: Cell Cycle, Cell Death, and Cancer. Advances in cancer research. 71. 1–25. 253 indexed citations
10.
Pieper, Russell O., Susan E. Morgan, & Mark R. Kelley. (1994). The role of two conserved amino acids, glutamine 90 and asparagine 137, in O6-methylguanine-DNA methyltransferase stability, activity and substrate specificity. Carcinogenesis. 15(9). 1895–1902. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026